CDH1 is upregulated in proliferating ovarian cancers, in which its suppression inhibits their proliferation [83, 84] and its proliferation-promoting effects in this context have been shown to occur via mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway activation [85]. The gene discussed is WNK2; the disease is ovarian cancer.